name,pdb_id,pubmed_id,resolution,uniprot,PFAM,CATH,receptor_chain,receptor_length,peptide_chain,peptide_length,sequence_alignment,stride,percent_exposed_alignment,cluster_number,binding_mode,size_of_binding_mode,core_ecr_alignment,longest_continuous_core,longest_continuous_ecr,corebinding_aa,exosite_aa,surface_aa,interior_aa,corebinding_ss,exosite_ss,surface_ss,interior_ss,unique_id,COREBINDING_aa,COREBINDING_ss,EXOSITE_aa,EXOSITE_ss,bfact,bs_loc_type,full_peptide_sequece,mean_seq_iden_in_bm,mean_seq_iden_not_bm,min_dist_E_C_diff_bm,occupancy,pep_loc_type,title
2QOS_C_A_87_3.pdb,2QOS,17692377,1.81,P07360,PF00061,2.40.128.20,C,173,A,11,LRYDSTAERLY,CCEEGGGCEEC,22010000103,87,3,1,CCCCCCCCCCC,11,0,A:0;E:0;F:0;K:0;L:0;Q:0;R:0;S:0;T:0;V:0;W:0;Y:0,A:0;E:0;F:0;K:0;L:0;Q:0;R:0;S:0;T:0;V:0;W:0;Y:0,A:5;D:3;E:2;F:1;G:4;H:2;K:1;L:1;N:1;P:1;Q:5;R:4;S:3;T:2;Y:1,A:16;C:2;D:5;E:6;F:8;G:9;H:3;I:4;K:2;L:10;M:1;P:4;Q:9;R:5;S:5;T:5;V:14;W:1;Y:4,B:0;C:0;E:0;H:0;T:0,B:0;C:0;E:0;H:0;T:0,C:11;G:6;H:4;T:15,B:1;C:23;E:55;G:7;H:14;T:13,87_3,A:1;E:1;F:2;K:1;L:6;Q:1;R:3;S:2;T:2;V:3;W:1;Y:1,B:1;C:2;E:18;H:2;T:1,A:0;E:0;F:0;K:0;L:0;Q:0;R:0;S:0;T:0;V:0;W:0;Y:0,B:0;C:0;E:0;H:0;T:0,75344344567,ALA_31_C_COREBINDING;ARG_113_C_COREBINDING;ARG_61_C_COREBINDING;ARG_91_C_COREBINDING;GLN_72_C_COREBINDING;GLU_170_C_COREBINDING;LEU_111_C_COREBINDING;LEU_168_C_COREBINDING;LEU_24_C_COREBINDING;LEU_34_C_COREBINDING;LEU_63_C_COREBINDING;LEU_85_C_COREBINDING;LYS_120_C_COREBINDING;PHE_153_C_COREBINDING;PHE_33_C_COREBINDING;SER_118_C_COREBINDING;SER_29_C_COREBINDING;THR_44_C_COREBINDING;THR_59_C_COREBINDING;TRP_68_C_COREBINDING;TYR_122_C_COREBINDING;VAL_27_C_COREBINDING;VAL_70_C_COREBINDING;VAL_94_C_COREBINDING,LRYDSTAERLY,-1,0.187861271676301,,99999999999,LEU_1_A_C;ARG_2_A_C;TYR_3_A_C;ASP_4_A_C;SER_5_A_C;THR_6_A_C;ALA_7_A_C;GLU_8_A_C;ARG_9_A_C;LEU_10_A_C;TYR_11_A_C,"CRYSTAL STRUCTURE OF COMPLEMENT PROTEIN C8 IN COMPLEX WITH 2 A PEPTIDE CONTAINING THE C8 BINDING SITE ON C8"
4MVI_A_B_87_1.pdb,4MVI,27029347,1.70,P80188,PF00061,2.40.128.20,A,172,B,13,KLVFFAEDVGSNK,CTTTTTTTTTTCC,5100000000124,87,1,3,eeCCCCCCDDDED,6,5,A:0;F:0;G:0;H:0;K:0;L:0;N:0;P:0;Q:0;R:0;S:0;T:0;V:0;W:0;Y:0,A:0;F:0;G:0;H:0;K:0;L:0;N:0;P:0;Q:0;R:0;S:0;T:0;V:0;W:0;Y:0,D:5;E:6;G:1;I:2;K:4;L:1;N:4;P:6;Q:4;R:4;S:5;T:2,A:4;C:2;D:2;E:3;F:8;G:8;H:3;I:7;K:8;L:10;M:2;N:5;P:4;Q:4;R:4;S:6;T:5;V:9;W:1;Y:3,B:0;C:0;E:0;T:0,B:0;C:0;E:0;T:0,C:14;E:3;G:3;H:3;T:21,B:1;C:22;E:43;G:3;H:15;T:14,87_1,A:1;F:3;G:2;H:1;K:3;L:1;N:1;P:1;Q:0;R:1;S:1;T:2;V:6;W:1;Y:4,B:1;C:3;E:23;T:1,A:0;F:0;G:0;H:0;K:0;L:0;N:0;P:0;Q:1;R:0;S:0;T:1;V:0;W:0;Y:0,B:0;C:0;E:2;T:0,7544444445678,ALA_101_A_COREBINDING;ARG_76_A_COREBINDING;ASN_129_A_COREBINDING;GLN_122_A_EXOSITE;GLY_65_A_COREBINDING;GLY_67_A_COREBINDING;HIS_72_A_COREBINDING;LEU_89_A_COREBINDING;LYS_35_A_COREBINDING;LYS_45_A_COREBINDING;LYS_74_A_COREBINDING;PHE_118_A_COREBINDING;PHE_66_A_COREBINDING;PHE_78_A_COREBINDING;PRO_164_A_COREBINDING;SER_63_A_COREBINDING;THR_131_A_COREBINDING;THR_49_A_COREBINDING;THR_99_A_EXOSITE;TRP_44_A_COREBINDING;TYR_133_A_COREBINDING;TYR_47_A_COREBINDING;TYR_51_A_COREBINDING;TYR_73_A_COREBINDING;VAL_103_A_COREBINDING;VAL_120_A_COREBINDING;VAL_28_A_COREBINDING;VAL_31_A_COREBINDING;VAL_61_A_COREBINDING;VAL_64_A_COREBINDING,DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVV,0.956395348837209,0.511073396961957,0.897905340222452,9999999999999,LYS_1_B_e;LEU_2_B_e;VAL_3_B_C;PHE_4_B_C;PHE_5_B_C;ALA_6_B_C;GLU_7_B_C;ASP_8_B_C;VAL_9_B_E;GLY_10_B_E;SER_11_B_E;ASN_12_B_E;LYS_13_B_E,"CRYSTAL STRUCTURE OF AN ENGINEERED LIPOCALIN ANTICALIN US7 IN 2 COMPLEX WITH THE ALZHEIMER AMYLOID PEPTIDE ABETA140"
4MVK_A_B_87_1.pdb,4MVK,27029347,1.50,P80188,PF00061,2.40.128.20,A,171,B,6,--VFFAED-----,--CCCCCC-----,--101000-----,87,1,3,--CCCCCC-----,6,0,A:0;F:0;G:0;H:0;K:0;L:0;N:0;P:0;R:0;S:0;T:0;V:0;W:0;Y:0,A:0;F:0;G:0;H:0;K:0;L:0;N:0;P:0;R:0;S:0;T:0;V:0;W:0;Y:0,D:4;E:6;G:1;K:5;L:1;N:4;P:5;Q:3;R:4;S:6;T:2,A:4;C:2;D:2;E:3;F:8;G:8;H:3;I:9;K:8;L:10;M:2;N:5;P:5;Q:6;R:4;S:5;T:5;V:10;W:1;Y:3,B:0;C:0;E:0;T:0,B:0;C:0;E:0;T:0,C:10;E:2;G:4;H:3;T:22,B:1;C:22;E:46;G:2;H:15;T:17,87_1,A:1;F:3;G:2;H:1;K:2;L:1;N:1;P:1;R:1;S:1;T:3;V:5;W:1;Y:4,B:1;C:2;E:23;T:1,A:0;F:0;G:0;H:0;K:0;L:0;N:0;P:0;R:0;S:0;T:0;V:0;W:0;Y:0,B:0;C:0;E:0;T:0,--444444-----,ALA_100_A_COREBINDING;ARG_75_A_COREBINDING;ASN_128_A_COREBINDING;GLY_64_A_COREBINDING;GLY_66_A_COREBINDING;HIS_71_A_COREBINDING;LEU_88_A_COREBINDING;LYS_44_A_COREBINDING;LYS_73_A_COREBINDING;PHE_117_A_COREBINDING;PHE_65_A_COREBINDING;PHE_77_A_COREBINDING;PRO_163_A_COREBINDING;SER_62_A_COREBINDING;THR_130_A_COREBINDING;THR_48_A_COREBINDING;THR_98_A_COREBINDING;TRP_43_A_COREBINDING;TYR_132_A_COREBINDING;TYR_46_A_COREBINDING;TYR_50_A_COREBINDING;TYR_72_A_COREBINDING;VAL_119_A_COREBINDING;VAL_27_A_COREBINDING;VAL_30_A_COREBINDING;VAL_60_A_COREBINDING;VAL_63_A_COREBINDING,VFFAED,0.959081327349381,0.510580400905926,,--999999-----,VAL_1_B_C;PHE_2_B_C;PHE_3_B_C;ALA_4_B_C;GLU_5_B_C;ASP_6_B_C,"CRYSTAL STRUCTURE OF AN ENGINEERED LIPOCALIN ANTICALIN US7 IN 2 COMPLEX WITH THE ALZHEIMER AMYLOID PEPTIDE FRAGMENT VFFAED"
4MVL_D_H_87_1.pdb,4MVL,27029347,2.30,P80188,PF00061,2.40.128.20,D,171,H,9,--VFFAEDVGS--,--CCCTTTTCC--,--102000142--,87,1,3,--CCCCCCddd--,6,3,A:0;D:0;E:0;F:0;G:0;K:0;L:0;N:0;R:0;S:0;T:0;V:0;W:0;Y:0,A:0;D:0;E:1;F:0;G:0;K:0;L:0;N:0;R:0;S:0;T:0;V:0;W:0;Y:0,D:6;E:7;G:2;I:1;K:7;L:1;N:4;P:3;Q:3;R:4;S:5;T:1;Y:1,A:5;C:2;D:1;E:3;F:9;G:8;H:3;I:8;K:6;L:11;M:2;N:5;P:8;Q:5;R:2;S:4;T:7;V:11;W:1;Y:3,C:0;E:0,C:0;E:1,C:8;E:5;G:4;H:4;T:24,B:2;C:26;E:42;G:2;H:14;T:18,87_1,A:1;D:1;E:0;F:2;G:1;K:1;L:3;N:1;R:1;S:1;T:2;V:3;W:1;Y:3,C:1;E:20,A:0;D:0;E:0;F:0;G:0;K:0;L:0;N:0;R:0;S:0;T:0;V:0;W:0;Y:0,C:0;E:0,--434444444--,ALA_30_D_COREBINDING;ARG_75_D_COREBINDING;ASN_128_D_COREBINDING;ASP_66_D_COREBINDING;GLU_119_D_exosite;GLY_64_D_COREBINDING;LEU_43_D_COREBINDING;LEU_71_D_COREBINDING;LEU_88_D_COREBINDING;LYS_73_D_COREBINDING;PHE_117_D_COREBINDING;PHE_77_D_COREBINDING;SER_62_D_COREBINDING;THR_130_D_COREBINDING;THR_48_D_COREBINDING;TRP_100_D_COREBINDING;TYR_132_D_COREBINDING;TYR_46_D_COREBINDING;TYR_50_D_COREBINDING;VAL_102_D_COREBINDING;VAL_27_D_COREBINDING;VAL_63_D_COREBINDING,DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVV,0.921290629674963,0.501876077476929,0.776496619438872,--999999999--,VAL_1_H_C;PHE_2_H_C;PHE_3_H_C;ALA_4_H_C;GLU_5_H_C;ASP_6_H_C;VAL_7_H_e;GLY_8_H_e;SER_9_H_e,"CRYSTAL STRUCTURE OF AN ENGINEERED LIPOCALIN ANTICALIN H1GA IN 2 COMPLEX WITH THE ALZHEIMER AMYLOID PEPTIDE ABETA140"
4QAE_F_U_87_2.pdb,4QAE,,2.10,P80188,PF00061,2.40.128.20,F,164,U,25,DTHFPICIFCCGCCHRSKCGMCCKT,CCCCCCEEEEETTTTTTTEEEEECC,5233221000000212010010224,87,2,1,CCCCCCCCCCCCCCCCCCCCCCCCC,25,0,D:0;E:0;I:0;L:0;M:0;N:0;Q:0;R:0;T:0;V:0;W:0,D:0;E:0;I:0;L:0;M:0;N:0;Q:0;R:0;T:0;V:0;W:0,A:1;D:5;E:6;F:1;G:1;K:4;L:1;N:4;P:3;Q:2;S:4;T:1,A:4;C:2;D:1;E:5;F:10;G:8;H:3;I:6;K:6;L:10;M:2;N:4;P:8;Q:5;R:4;S:4;T:7;V:13;W:1;Y:6,C:0;E:0;T:0,C:0;E:0;T:0,C:5;E:4;G:4;H:3;T:17,B:2;C:22;E:58;G:5;H:11;T:11,87_2,D:1;E:2;I:1;L:4;M:2;N:1;Q:2;R:1;T:1;V:4;W:3,C:2;E:13;T:7,D:0;E:0;I:0;L:0;M:0;N:0;Q:0;R:0;T:0;V:0;W:0,C:0;E:0;T:0,9998664433333333333333467,ARG_118_F_COREBINDING;ASN_34_F_COREBINDING;ASP_42_F_COREBINDING;GLN_116_F_COREBINDING;GLN_76_F_COREBINDING;GLU_35_F_COREBINDING;GLU_39_F_COREBINDING;ILE_63_F_COREBINDING;LEU_31_F_COREBINDING;LEU_37_F_COREBINDING;LEU_74_F_COREBINDING;LEU_89_F_COREBINDING;MET_44_F_COREBINDING;MET_65_F_COREBINDING;THR_92_F_COREBINDING;TRP_115_F_COREBINDING;TRP_122_F_COREBINDING;TRP_47_F_COREBINDING;VAL_113_F_COREBINDING;VAL_114_F_COREBINDING;VAL_120_F_COREBINDING;VAL_36_F_COREBINDING,DTHFPICIFCCGCCHRSKCGMCCKT,-1,0.669279388539458,,9999999999999999999999999,ASP_1_U_C;THR_2_U_C;HIS_3_U_C;PHE_4_U_C;PRO_5_U_C;ILE_6_U_C;CYS_7_U_C;ILE_8_U_C;PHE_9_U_C;CYS_10_U_C;CYS_11_U_C;GLY_12_U_C;CYS_13_U_C;CYS_14_U_C;HIS_15_U_C;ARG_16_U_C;SER_17_U_C;LYS_18_U_C;CYS_19_U_C;GLY_20_U_C;MET_21_U_C;CYS_22_U_C;CYS_23_U_C;LYS_24_U_C;THR_25_U_C,"CRYSTAL STRUCTURE OF AN ENGINEERED LIPOCALIN ANTICALIN IN COMPLEX 2 WITH HUMAN HEPCIDIN"
